EarlySense, a Waltham, MA- and Ramat Gan, Israel-based provider of contact-free continuous monitoring solutions, completed a $25m round of funding.
The round was led by Bank Hapoalim, with participation from Pitango Venture Capital, JK&B Capital and other previous investors.
The company, which has raised $100m to date, intends to use the funds to continue to grow as well as launch consumer digital health offerings based on its proven technology.
Founded in 2004 and led by Avner Halperin, CEO, EarlySense provides a FDA-cleared and CE-approved contact-free monitoring system that enables healthcare professionals to track patient heart rate, respiratory rate and movement constantly through a sensor placed under the mattress.
Continuous data is displayed on the bedside monitor and in nurse monitoring stations and is also delivered to healthcare professionals’ smart-devices.
The company’s technology leverages Big Data and advanced algorithms to generate accurate health information allowing clinicians to achieve early detection of adverse events and improved patient outcomes. The product also powers several consumer health products including Samsung’s SleepSense, iFit’s Sleep Sensor and Beurer’s SE 80 Sleep Expert.